Ironwood Pharmaceuticals (IRWD) Current Taxes (2020 - 2026)

Ironwood Pharmaceuticals has disclosed Current Taxes across 6 years of filings, most recently posting $3.9 million for Q1 2026.

• Current Taxes for Q1 2026 came in at $3.9 million, up 440.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (up 440.08% YoY), and the FY2025 annual result was $927000.0, up 77.93% from the prior year.
• Current Taxes came in at $3.9 million for Q1 2026 at Ironwood Pharmaceuticals, up from $927000.0 in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $6.6 million in Q2 2023 to a low of $521000.0 in Q4 2024.
• The 5-year median for Current Taxes is $935000.0 (2024), against an average of $1.6 million.
• Across the five-year window, Current Taxes slumped 85.93% in 2024 and surged 440.08% in 2026, its largest moves.
• Ironwood Pharmaceuticals' Current Taxes stood at $656000.0 in 2022, then jumped by 89.63% to $1.2 million in 2023, then slumped by 58.12% to $521000.0 in 2024, then soared by 77.93% to $927000.0 in 2025, then jumped by 320.06% to $3.9 million in 2026.
• The last three Current Taxes figures came in at $3.9 million (Q1 2026), $927000.0 (Q4 2025), and $656000.0 (Q3 2025), per Business Quant data.